Skip to content

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05279729
Enrollment
45
Registered
2022-03-15
Start date
2022-08-01
Completion date
2028-12-31
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Obesity

Keywords

diabetes, low income, mhealth, ehealth

Brief summary

The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and the subsequent benefit of improving type II diabetes outcomes in a low socioeconomic Hispanic population. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

Interventions

Intervention will be with two different mobile health (mHealth) applications, Weight Watchers and Healthi app (formerly iTrackBites)

Sponsors

San Diego State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with type II diabetes * Between the age of 18-64 * BMI ≥ 27 * Individual annual income less than $47,520 \[Covered CA income guidelines and salary restrictions\] * Hispanic and/or Latinx origin * Monitors blood glucose regularly * Owns or has access to a bathroom weight scale * Owns a smartphone and willing to download mobile apps

Exclusion criteria

* Does not check blood glucose at least once per day * On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications. Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are okay

Design outcomes

Primary

MeasureTime frameDescription
Most effect intervention for weight loss in first 3 months6 monthsCompare the three interventions, mHealth apps and control, against each other to determine which is most effective at achieving the maximum amount of weight loss within the first three months
Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire6 monthsCompare and determine which intervention promotes self-efficacy in weight management
Long term diabetes improvement via A1c6 monthsCompare and determine which intervention provides the best improvements towards diabetes via blood glucose and HbA1c
Effectiveness of mHealth apps at reducing bodyweight assessed by bodyweight measurements over 6 months6 monthsDetermine if mHealth apps-Weight Watchers (WW) and Healthi app-are an effective weight loss modality compared to standard weight loss program (control)
Most effective intervention for weight loss by 6 months6 monthsCompare and determine which intervention leads to the highest weight loss maintenance after six months

Secondary

MeasureTime frameDescription
mhealthy app preference assessed by questionnaire6 monthsWhich mHealth app is more economically feasible for the participants and if feasibility changes after app usage. Outcome will be assessed with a questionnaire asking if the participant can afford the app.
Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire6 monthsComparing the three interventions to determine which leads to greater quality of life (QOL)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026